Disordered Proteostasis as a Driver of Disease in the Aging Lung
蛋白质稳态紊乱是衰老肺疾病的驱动因素
基本信息
- 批准号:10208506
- 负责人:
- 金额:$ 31.75万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2015
- 资助国家:美国
- 起止时间:2015-07-01 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAcuteAddressAdult Respiratory Distress SyndromeAffectAgingAgonistAlveolarAlveolar MacrophagesAutopsyBiological MarkersBiopsyBloodBlood Coagulation FactorBronchoalveolar Lavage FluidC-reactive proteinCOVID-19Cardiovascular systemCause of DeathCell DeathCellsClinicalClinical TrialsCoagulation ProcessDataDiffuseDiseaseDisease modelDistantElderlyEndothelial CellsEndotheliumEpithelial CellsEvaluationFunctional disorderGenetic TranscriptionHeartHumanHypotensionHypoxemiaIL6 geneImmuneIndividualInfectionInflammasomeInflammationInflammatoryInfluenza A virusInterleukin-1Interleukin-6IntubationIrrigationKidneyLinkLiquid substanceLiverLungLymphocyteMacrophage ActivationMechanical ventilationMediatingModelingMorbidity - disease rateMuscleOrganPatientsPneumoniaPrimatesPublishingReportingResearch PersonnelRespiratory FailureRodentRoleSamplingSerumSliceSourceSpleenTestingTherapeuticThromboplastinThrombosisTimeTissue HarvestingTissuesViralViral PneumoniaVirusVirus Replicationage relatedagedbasecytokinecytokine release syndromeexperimental studyinhibitor/antagonistlymph nodesmacrophagemonocytemortalityneutrophilorgan injurypreventproteostasisrespiratory virusresponsesingle-cell RNA sequencingsounduptake
项目摘要
Pneumonia is the leading cause of death in patients with COVID-19 infection and disproportionately affects older
individuals. In addition to the diffuse patchy alveolar infiltrates and acute hypoxemic respiratory failure typical of
viral pneumonia, patients with COVID-19 often develop hypotension requiring alpha-adrengergic agonists, very
high serum levels of IL-6 and its transcriptional target C-Reactive Protein (CRP) and display evidence of
intravascular coagulation. This is accompanied by the death of cells in multiple tissues including the kidney,
muscle, liver and occasionally the heart. This end-organ injury is an important driver of morbidity and perhaps
mortality in COVID-19 patients. These unusual clinical features suggest a virus-induced cytokine storm, but the
underlying mechanisms are unknown and these clinical features are not recapitulated in rodent or primate
models of the disease.Our early analysis of bronchoalveolar lavage fluid collected from the alveolar space of
patients with severe COVID-19 pneumonia requiring mechanical ventilation challenge the existing paradigm that
IL-6 originates in immune cells within the alveolar space. Specifically, we found that at the time of intubation, the
alveolar space in the majority of patients with severe COVID-19-induced ARDS harbors mature alveolar
macrophages and lymphocytes none of which produce IL-6. Instead, a subset of resident alveolar macrophages
produce IL-1? and appear to support replication of SARS-CoV-2.We hypothesize that disordered
proteostasis in alveolar macrophages from aged individuals prevents viral killing after uptake of SARS-
CoV-2. Replicating virus activates the inflammasome to induce IL-1? release in the lung, which in turn induces
the release of IL-6 from endothelial cells in the lung and distant organs. We will test this hypothesis in two related
experiments. Experiment 1. To determine whether activation of the inflammasome in response to COVID-
19 infection is necessary for the release of IL-6 from the lung endothelium. We will infect lung slices from
normal human donors with SARS-CoV-2 in the presence or absence of an IL-1? inhibitor that is under evaluation
as a therapy for patients with COVID-19 associate pneumonia (canakinumab). We will examine the lung slices
after infection using single cell RNA-Seq and RNAscope. Experiment 2. To determine whether endothelial
cells in tissues outside the lung express IL6 in patients with severe COVID-19. We will perform RNAscope
on fixed tissues harvested from 9 patients who have undergone autopsy after COVID-19 at Northwestern and
RNAscope plus single cell RNA-Seq on lung, kidney, spleen and lymph nodes from 5 patients who undergo post-
mortem biopsy in our ICU.
肺炎是COVID-19感染患者死亡的主要原因,对老年人的影响不成比例
个体除了弥漫性斑片状肺泡浸润和典型的急性低氧性呼吸衰竭,
病毒性肺炎,COVID-19患者经常发生低血压,需要α-肾上腺素能受体激动剂,
IL-6及其转录靶点C-反应蛋白(CRP)血清水平升高,
血管内凝血这伴随着包括肾脏在内的多种组织中的细胞死亡,
肌肉肝脏偶尔还有心脏这种终末器官损伤是发病率的重要驱动因素,
COVID-19患者的死亡率。这些不寻常的临床特征表明病毒诱导的细胞因子风暴,但
潜在的机制尚不清楚,这些临床特征在啮齿动物或灵长类动物中未重现
我们早期分析了从哮喘患者的肺泡腔收集的支气管肺泡灌洗液,
需要机械通气的严重COVID-19肺炎患者挑战了现有的范式,
IL-6来源于肺泡腔内的免疫细胞。具体来说,我们发现在插管时,
大多数严重COVID-19诱导的ARDS患者的肺泡腔含有成熟的肺泡
巨噬细胞和淋巴细胞都不产生IL-6。相反,一部分肺泡巨噬细胞
产生IL-1?并且似乎支持SARS-CoV-2的复制。我们假设,
老年人肺泡巨噬细胞的蛋白质稳态阻止了SARS病毒的杀伤作用-
二型冠状病毒复制病毒激活炎性小体诱导IL-1?在肺中释放,这反过来又诱导
肺和远端器官内皮细胞释放IL-6。我们将在两个相关的实验中验证这一假设。
实验实验1.为了确定炎症小体的激活是否响应于COVID-19,
19感染对于从肺内皮释放IL-6是必需的。我们将感染来自
正常人捐助者与SARS-CoV-2的存在或不存在的IL-1?正在评估的抑制剂
作为COVID-19相关肺炎患者的治疗(卡那单抗)。我们会检查肺部切片
感染后使用单细胞RNA-Seq和RNAscope。实验2.为了确定内皮细胞是否
在严重的COVID-19患者中,肺外组织中的细胞表达IL 6。我们将执行RNAscope
从9名在西北大学接受COVID-19尸检的患者身上采集的固定组织,
RNAscope加单细胞RNA-Seq对来自5名患者的肺、肾、脾和淋巴结的研究,
尸检活组织检查
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
GR Scott Budinger其他文献
GR Scott Budinger的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('GR Scott Budinger', 18)}}的其他基金
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
针对 COVID-19 中异常的肺泡免疫激活和失败的上皮修复
- 批准号:
10596990 - 财政年份:2022
- 资助金额:
$ 31.75万 - 项目类别:
Microglia mediate cognitive dysfunction in elderly survivors of pneumonia
小胶质细胞介导老年肺炎幸存者的认知功能障碍
- 批准号:
10354214 - 财政年份:2022
- 资助金额:
$ 31.75万 - 项目类别:
Targeting abnormal alveolar immune activation and failed epithelial repair in COVID-19
针对 COVID-19 中异常的肺泡免疫激活和失败的上皮修复
- 批准号:
10391970 - 财政年份:2022
- 资助金额:
$ 31.75万 - 项目类别:
Project 3: Targeting linear ubiquitination to attenuate inflammation and promote repair after viral pneumonia
项目3:靶向线性泛素化以减轻病毒性肺炎后的炎症并促进修复
- 批准号:
10696965 - 财政年份:2021
- 资助金额:
$ 31.75万 - 项目类别:
Project 3: Targeting linear ubiquitination to attenuate inflammation and promote repair after viral pneumonia
项目3:靶向线性泛素化以减轻病毒性肺炎后的炎症并促进修复
- 批准号:
10269676 - 财政年份:2021
- 资助金额:
$ 31.75万 - 项目类别:
Disordered Proteostasis as a Driver of Disease in the Aging Lung
蛋白质稳态紊乱是衰老肺疾病的驱动因素
- 批准号:
10197736 - 财政年份:2015
- 资助金额:
$ 31.75万 - 项目类别:
Alveolar Macrophages as Age-Related Drivers of Disordered Tissue Repair
肺泡巨噬细胞作为紊乱组织修复的年龄相关驱动因素
- 批准号:
10197742 - 财政年份:2015
- 资助金额:
$ 31.75万 - 项目类别:
Alveolar Macrophages as Age-Related Drivers of Disordered Tissue Repair
肺泡巨噬细胞作为紊乱组织修复的年龄相关驱动因素
- 批准号:
10417059 - 财政年份:2015
- 资助金额:
$ 31.75万 - 项目类别:
Disordered Proteostasis as a Driver of Disease in the Aging Lung
蛋白质稳态紊乱是衰老肺疾病的驱动因素
- 批准号:
9751135 - 财政年份:2015
- 资助金额:
$ 31.75万 - 项目类别:
Disordered Proteostasis as a Driver of Disease in the Aging Lung
蛋白质稳态紊乱是衰老肺疾病的驱动因素
- 批准号:
9779491 - 财政年份:2015
- 资助金额:
$ 31.75万 - 项目类别:
相似海外基金
Acute senescence: a novel host defence counteracting typhoidal Salmonella
急性衰老:对抗伤寒沙门氏菌的新型宿主防御
- 批准号:
MR/X02329X/1 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Fellowship
Transcriptional assessment of haematopoietic differentiation to risk-stratify acute lymphoblastic leukaemia
造血分化的转录评估对急性淋巴细胞白血病的风险分层
- 批准号:
MR/Y009568/1 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Fellowship
Combining two unique AI platforms for the discovery of novel genetic therapeutic targets & preclinical validation of synthetic biomolecules to treat Acute myeloid leukaemia (AML).
结合两个独特的人工智能平台来发现新的基因治疗靶点
- 批准号:
10090332 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Collaborative R&D
Cellular Neuroinflammation in Acute Brain Injury
急性脑损伤中的细胞神经炎症
- 批准号:
MR/X021882/1 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Research Grant
STTR Phase I: Non-invasive focused ultrasound treatment to modulate the immune system for acute and chronic kidney rejection
STTR 第一期:非侵入性聚焦超声治疗调节免疫系统以治疗急性和慢性肾排斥
- 批准号:
2312694 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Standard Grant
Combining Mechanistic Modelling with Machine Learning for Diagnosis of Acute Respiratory Distress Syndrome
机械建模与机器学习相结合诊断急性呼吸窘迫综合征
- 批准号:
EP/Y003527/1 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Research Grant
FITEAML: Functional Interrogation of Transposable Elements in Acute Myeloid Leukaemia
FITEAML:急性髓系白血病转座元件的功能研究
- 批准号:
EP/Y030338/1 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Research Grant
KAT2A PROTACs targetting the differentiation of blasts and leukemic stem cells for the treatment of Acute Myeloid Leukaemia
KAT2A PROTAC 靶向原始细胞和白血病干细胞的分化,用于治疗急性髓系白血病
- 批准号:
MR/X029557/1 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Research Grant
ロボット支援肝切除術は真に低侵襲なのか?acute phaseに着目して
机器人辅助肝切除术真的是微创吗?
- 批准号:
24K19395 - 财政年份:2024
- 资助金额:
$ 31.75万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Collaborative Research: Changes and Impact of Right Ventricle Viscoelasticity Under Acute Stress and Chronic Pulmonary Hypertension
合作研究:急性应激和慢性肺动脉高压下右心室粘弹性的变化和影响
- 批准号:
2244994 - 财政年份:2023
- 资助金额:
$ 31.75万 - 项目类别:
Standard Grant